1572
MI related to the use of activated and non-activated PCCs predominantly affects young patients who often have no preceding history of, or risk factors for, MI and tends to be associated with large cumulative doses of concentrate.
 ( adverse event: related ,  young patients who often have no preceding history of, or risk factors for, MI: Subject, young: Subject.Age, MI: Effect, activated and non-activated PCCs: Treatment, large cumulative doses of concentrate: Treatment, non-activated PCCs: Treatment.Drug, activated: Treatment.Drug, PCCs: Treatment.Drug, large cumulative doses: Treatment.Dosage) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: related ,  young patients who often have no preceding history of, or risk factors for, MI: Subject, young: Subject.Age, MI: Effect, activated and non-activated PCCs: Treatment, large cumulative doses of concentrate: Treatment, non-activated PCCs: Treatment.Drug, activated: Treatment.Drug, PCCs: Treatment.Drug, large cumulative doses: Treatment.Dosage) 